Investor Atlas

2080 Ventures · Investor research

46 investors focused on Biotech targeting Australia

Compare 46 investors focused on Biotech targeting Australia. Review the selection, investor types and reported focus with 2080 Ventures.

46matching investors
1individual investors
45organizations

What this selection covers

This guide contains 46 distinct directory identities matching target markets: Australia; sectors: Biotech. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting Australia” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Investor types represented: Venture Capital (39), Accelerator (5), Corporate Venture Capital (3), Family Office (2).

Prepare a focused approach

Explain the development pathway, validation milestones and capital needed to reach the next evidence point.

Before pitching for Australia, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

  1. Check the current mandate and recent investments.
  2. Confirm check size, lead or follow preference, and company eligibility.
  3. Identify the relevant partner and published pitch route.
  4. Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 46 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

InvestorInvestor typeResearch
AbbVie
Venture Capital, Corporate Venture CapitalView profile ↗
Airtree Ventures
Venture CapitalView profile ↗
Alumni Ventures
Venture CapitalView profile ↗
Amadeus Capital Partners
Venture CapitalView profile ↗
Andreessen Horowitz
Venture CapitalView profile ↗
Antler
Venture CapitalView profile ↗
ArcTern Ventures
Venture CapitalView profile ↗
Astanor Ventures
Venture CapitalView profile ↗
Atlas Venture
Venture CapitalView profile ↗
Bain Capital
Venture CapitalView profile ↗
Bain Capital Ventures
Venture Capital, Corporate Venture CapitalView profile ↗
Berkeley SkyDeck
AcceleratorView profile ↗
Boost VC
Venture Capital, AcceleratorView profile ↗
Breakthrough Energy Ventures
Venture CapitalView profile ↗
DBJ Capital
Venture CapitalView profile ↗
Deepbridge Capital
Venture CapitalView profile ↗
EXPERT DOJO
Venture Capital, AcceleratorView profile ↗
Fiddlehead Ventures
Venture CapitalView profile ↗
Fifty Years
Venture CapitalView profile ↗
Flashpoint VC
Venture CapitalView profile ↗
General Atlantic
Venture CapitalView profile ↗
Global Founders Capital
Venture Capital, Family OfficeView profile ↗
Gobi Partners
Venture CapitalView profile ↗
Granite Asia
Venture CapitalView profile ↗
Great Eagle Holdings
Corporate Venture CapitalView profile ↗
Index Ventures
Venture CapitalView profile ↗
IndieBio
Venture CapitalView profile ↗
Khosla Ventures
Venture CapitalView profile ↗
Lowercarbon Capital
Venture CapitalView profile ↗
MedTech Actuator
AcceleratorView profile ↗
Michael Wieser
Angel InvestorView profile ↗
MTPConnect
AcceleratorView profile ↗
Neotribe Ventures
Venture CapitalView profile ↗
Notion Capital
Venture CapitalView profile ↗
Ocean Azul Partners
Venture CapitalView profile ↗
Pear VC
Venture CapitalView profile ↗
Peregrine Ventures
Venture CapitalView profile ↗
Pioneer Fund
Venture Capital, SyndicateView profile ↗
Sentor Investments
Family OfficeView profile ↗
Signet Healthcare Partners
Venture CapitalView profile ↗
Stray Dog Capital
Venture CapitalView profile ↗
SV Health Investors
Venture CapitalView profile ↗
True Ventures
Venture CapitalView profile ↗
Venrock
Venture CapitalView profile ↗
Wellcome Trust
Public FundView profile ↗
Western Technology Investment
Venture CapitalView profile ↗

How these guides are compiled. Source-reported criteria may change. A listing does not confirm current investment activity.